Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis
Abstract Background Immune checkpoint inhibitors have shown promise in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) advanced colorectal cancer (CRC) immunotherapy, and many clinical trials have been conducted. Objective To evaluate the efficacy and safety of PD-1/PD-L1 inhi...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2022-10-01
|
| Colecção: | BMC Gastroenterology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12876-022-02511-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|